Anti-PD-1 Induced Musculoskeletal Side Effects Successfully Treated With Hydroxychloroquine in Patients With Advanced Cutaneous Squamous Cell Carcinoma

Anti-PD-1 Induced Musculoskeletal Side Effects Successfully Treated With Hydroxychloroquine in Patients With Advanced Cutaneous Squamous Cell Carcinoma

Saved in:

Bibliographic Details
Main Authors:	I. Villegas-Romero, J.F. Millán-Cayetano, D. Jiménez-Gallo, T. Fernández-Morano, I. Navarro-Navarro, M. Linares-Barrios
Format:	Article
Language:	English
Published:	Elsevier 2024-11-01
Series:	Actas Dermo-Sifiliográficas
Online Access:	http://www.sciencedirect.com/science/article/pii/S0001731024005295
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

[Artículo traducido] Tratamiento con hidroxicloroquina de efectos secundarios musculoesqueléticos inducidos por anti-PD-1 en pacientes con carcinoma cutáneo de células escamosas avanzado
by: I. Villegas-Romero, et al.
Published: (2024-11-01)

Pembrolizumab treatment for advanced pleomorphic dermal sarcoma, a three-case series in a spanish tertiary-level hospital
by: R.P. Román Cheuque, et al.
Published: (2024-01-01)

Young patient diagnosed with hydroxychloroquine intoxication
by: Luis Olmos Gutiérrez, et al.
Published: (2017-05-01)

Dermatofibrosarcoma protuberans: casuística hospitalaria y comparativa en el manejo entre Dermatología y otras especialidades
by: M. Viedma-Martínez, et al.
Published: (2024-11-01)

[Translated article] Dermatofibrosarcoma Protuberans: Hospital Casuistry and Comparative Analysis in the Management of This Entity by the Dermatology Unit Compared to Other Units
by: M. Viedma-Martínez, et al.
Published: (2024-11-01)

Can Hydroxychloroquine Cause G6PD-Related Hemolysis? A Case Study
by: Khaldun Obeidat, et al.
Published: (2020-11-01)

Development of diffuse cutaneous squamous cell carcinoma in situ after chemotherapy for ovarian carcinoma and remission with PD1-inhibitor
by: Jess Durbin, et al.
Published: (2024-12-01)

Successful treatment of cardiac tamponade with systemic lupus erythematosus using belimumab and hydroxychloroquine
by: Tomoo Kise, et al.
Published: (2023-01-01)

Comment on: Assessing the risk of retinopathy in indian patients using hydroxychloroquine for rheumatic and musculoskeletal diseases: A retrospective observational study
by: Manesh Manoj, et al.
Published: (2021-01-01)

Assessing the risk of retinopathy in indian patients using hydroxychloroquine for rheumatic and musculoskeletal diseases: A retrospective observational study – Reply
by: Arindam Nandy Roy, et al.
Published: (2022-01-01)

Correspondence on “assessing the risk of retinopathy in Indian patients using hydroxychloroquine for rheumatic and musculoskeletal diseases: A retrospective observational study”
by: Nikunjkumar V Dadhaniya, et al.
Published: (2021-01-01)

A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma
by: J. Kaczmar, et al.
Published: (2024-01-01)

Correspondence on “assessing the risk of retinopathy in indian patients using hydroxychloroquine for rheumatic and musculoskeletal diseases: A retrospective observational study” – Reply
by: Arindam Nandy Roy, et al.
Published: (2021-01-01)

“Hemolysis, or not Hemolysis, that is the question”. Use of hydroxychloroquine in a patient with COVID-19 infection and G6PD deficiency.
by: NICOLA SGHERZA, et al.
Published: (2020-10-01)

Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma
by: Dirk Schadendorf, et al.
Published: (2022-12-01)

Cutaneous Squamous Cell Carcinoma of the Head and Neck
by: Vivek V. Gurudutt, et al.
Published: (2011-01-01)

Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma
by: Teresa Troiani, et al.
Published: (2025-01-01)

Hydroxychloroquine-induced auditory toxicity
by: Abhishek Patil, et al.
Published: (2020-01-01)

Rheumatologists’ perspective on hydroxychloroquine guidelines
by: Anca D Askanase, et al.
Published: (2020-10-01)

Cemiplimab Immunotherapy in the Treatment of Cutaneous Squamous Cell Carcinoma
by: Z. Kozéki, et al.
Published: (2024-01-01)

Outcomes of Recurrent Head and Neck Cutaneous Squamous Cell Carcinoma
by: Nichole R. Dean, et al.
Published: (2011-01-01)

Paraneoplastic bullous pemphigoid secondary to cutaneous squamous cell carcinoma
by: Karolina Zarańska, et al.
Published: (2025-01-01)

Cutaneous Squamous Cell Carcinoma with Invasion through Ear Cartilage
by: Julie Boisen, et al.
Published: (2016-01-01)

Clinical Risk Factors for Cutaneous Squamous Cell Carcinoma in Patients with Actinic Keratosis or Cutaneous Squamous Cell Carcinoma in Situ: A Retrospective Double-cohort Study
by: Jaakko S. Knuutila, et al.
Published: (2024-11-01)

Hydroxychloroquine’s Early Impact on Cone Density
by: Tomoko Ueda-Consolvo, et al.
Published: (2021-01-01)

Successful treatment of cutaneous polyarteritis nodosa with baricitinib
by: Shihui Zhou, et al.
Published: (2024-12-01)

Finally, successful interventions to ameliorate cutaneous infestations
by: Francisco Tausk
Published: (2024-12-01)

Cutaneous sarcoidosis successfully treated with PUVA therapy
by: Agata Szczecina, et al.
Published: (2025-01-01)

Primary Carcinoma in Squamous Cells of the Gallbladder
by: Javier Martínez Navarro, et al.
Published: (2018-09-01)

Prognostic and Predictive Non-Invasive Biomarkers in Cutaneous Melanoma Treated With Anti PD-1 Antibodies
by: S. Torres-Martínez, et al.
Published: (2023-11-01)

Pathological margins and advanced cutaneous squamous cell carcinoma of the head and neck
by: T. J. Phillips, et al.
Published: (2019-10-01)

Immunosuppression and Outcomes in Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck
by: Doriana Iancu, et al.
Published: (2025-01-01)

Anti‐retinal Autoantibodies in Hydroxychloroquine Eye Toxicity
by: Samuel D. Good, et al.
Published: (2025-01-01)

Analysis of hydroxychloroquine prescriptions for COVID‐19 in Japan
by: Takashi Watari, et al.
Published: (2023-05-01)

Syndecan-1 and E-Cadherin Expression in Canine Cutaneous Squamous Cell Carcinoma
by: Rita Files, et al.
Published: (2024-12-01)

Sunscreen Use and Cutaneous Squamous Cell Carcinoma Risk: A Review of the Evidence
by: Simon Lergenmuller, et al.
Published: (2025-01-01)

From actinic keratosis to cutaneous squamous cell carcinoma: the key pathogenesis and treatments
by: Zhenlin Li, et al.
Published: (2025-01-01)

Skin squamous cell carcinoma or Cutaneous Leishmaniasis? Case report and review of the literature
by: Resi Pucci, et al.
Published: (2023-09-01)

In-depth plasma proteomics reveals increase in circulating PD-1 during anti-PD-1 immunotherapy in patients with metastatic cutaneous melanoma
by: Yago Pico de Coaña, et al.
Published: (2020-05-01)

Liposomal Formulation of Hydroxychloroquine Can Inhibit Autophagy In Vivo
by: Wieslawa H. Dragowska, et al.
Published: (2024-12-01)